By Counterforce Health Team in Gilenya (fingolimod) —

How to Get Gilenya (fingolimod) Covered by Cigna in Florida: Prior Authorization, Appeals, and Success Strategies

Answer Box: Getting Gilenya (fingolimod) Covered by Cigna in Florida

Cigna requires prior authorization for Gilenya (fingolimod) with step therapy, baseline testing (EKG, eye exam, labs), and specialist prescription. Submit via CoverMyMeds or fax to 1-866-873-8279 with medical necessity documentation. If denied, request peer-to-peer review (1-800-882-4462) within 24-48 hours, then file internal appeal within 180 days. Florida members can pursue external review through the Department of Financial Services (1-877-693-5236) if internal appeals fail. First step today: Verify your formulary tier and PA requirements through your Cigna member portal.

Table of Contents

Coverage Requirements at a Glance

Requirement What It Means Where to Find It Source
Prior Authorization Required for all Gilenya requests Cigna formulary or member portal Cigna PA Policy
Step Therapy Must try preferred MS drugs first Coverage policy documents Step Therapy Policy
Specialist Prescription Neurologist or MS specialist required PA form requirements Gilenya PA Criteria
Baseline Testing EKG, ophthalmology exam, CBC, LFTs Clinical documentation FDA Gilenya Label
First-Dose Monitoring 6-hour cardiac observation plan Safety protocols FDA Safety Communication

Step-by-Step: Fastest Path to Approval

1. Verify Coverage and Requirements

Who: Patient
Action: Log into your Cigna member portal or call customer service
Timeline: Same day
What to check: Formulary tier, PA requirements, step therapy rules

2. Complete Baseline Testing

Who: Patient with neurologist
Required tests: EKG (within 6 months), comprehensive ophthalmology exam, CBC with differential, liver function tests
Timeline: 1-2 weeks
Documentation: Ensure all results are normal and documented

3. Document Prior Treatment History

Who: Neurologist/clinic staff
Required: Records of previous MS therapies, outcomes, side effects, contraindications
Focus areas: Step therapy compliance, medical necessity justification
Timeline: Ongoing documentation review

4. Submit Prior Authorization

Who: Prescribing neurologist
Method: CoverMyMeds portal or fax to 1-866-873-8279
Required documents: PA form, medical necessity letter, baseline test results, prior therapy records
Timeline: 2-5 business days for standard review, 24-72 hours for expedited

5. Follow Up on Decision

Who: Patient or clinic
Standard response time: 72 hours for most requests
If approved: Coordinate with specialty pharmacy (typically Express Scripts/Accredo)
If denied: Immediately request peer-to-peer review

6. Request Peer-to-Peer Review (If Denied)

Who: Neurologist
Contact: 1-800-882-4462 (Cigna Health Services)
Timing: Within 24-48 hours of denial
Duration: 15-20 minute consultation with Cigna medical director

7. File Appeals if Necessary

Who: Patient or authorized representative
Internal appeal deadline: 180 days from denial
External review: Available through Florida Department of Financial Services if internal appeals fail

Clinician Corner: Medical Necessity Documentation

Essential Elements for Your Medical Necessity Letter

Patient Clinical Profile:

  • Confirmed relapsing MS diagnosis with ICD-10 code G35
  • MRI evidence of disease activity or new lesions
  • EDSS scores or other objective disability measures
  • Documentation of relapses, frequency, and impact on daily function

Prior Treatment Documentation:

  • Specific MS therapies tried (drug names, doses, duration)
  • Clinical outcomes: efficacy measures, side effects, contraindications
  • Reasons for discontinuation or inadequate response
  • Step therapy compliance per Cigna's formulary requirements

Gilenya-Specific Justification:

  • Clinical rationale for fingolimod over alternatives
  • Expected outcomes and monitoring plan
  • Safety considerations and mitigation strategies
  • References to FDA labeling and MS treatment guidelines

Monitoring and Safety Plan:

  • First-dose observation protocol (6-hour cardiac monitoring)
  • Ongoing surveillance: ophthalmology, liver function, CBC
  • Patient counseling on infection risk and contraception (if applicable)
From our advocates: "We've seen the highest approval rates when neurologists include specific EDSS scores, MRI progression data, and detailed documentation of why previous therapies failed. A table comparing the patient's response to each prior MS drug—with dates, doses, and specific adverse events—makes the medical necessity crystal clear to reviewers."

Common Denial Reasons & How to Fix Them

Denial Reason How to Overturn Required Documentation
Incomplete step therapy Document all prior MS drug trials Pharmacy records, clinic notes showing failures/intolerances
Missing baseline tests Submit all required safety labs EKG, ophthalmology report, CBC, LFTs within required timeframes
Insufficient medical necessity Strengthen clinical justification MRI reports, relapse history, disability scores, treatment goals
Non-specialist prescriber Transfer prescription Neurologist or MS specialist must be prescribing physician
Missing monitoring plan Detail safety protocols First-dose observation plan, ongoing surveillance schedule
Quantity/duration limits Request exception with rationale Clinical evidence supporting requested quantity and duration

Appeals Playbook for Florida Cigna Members

Internal Appeal Process

Timeline: 180 days from denial notice
Submission methods:

  • Online: Cigna member portal
  • Mail: Address on denial letter
  • Fax: Number provided in denial documentation

Required documents:

  • Original denial letter
  • Updated medical necessity letter from neurologist
  • Additional clinical evidence (MRI, labs, treatment records)
  • Patient impact statement (optional but helpful)

Decision timeline:

  • Standard: 30 days for pre-service requests
  • Expedited: 72 hours for urgent medical situations

External Review (Florida-Specific)

When available: After exhausting internal appeals or if Cigna fails to follow proper procedures
Timeline: Request within 120 days of final internal denial
Cost: Free to consumers
Contact: Florida Department of Financial Services at 1-877-693-5236 or online at myfloridacfo.com

Process:

  1. Submit external review request with all documentation
  2. Independent medical expert reviews case (not affiliated with Cigna)
  3. Decision rendered within 45 days (72 hours for expedited)
  4. Decision is binding on Cigna if coverage is approved

Peer-to-Peer Review Strategy

Best timing: Immediately upon denial, before formal appeals
Success factors:

  • Neurologist preparation with complete medical records
  • Emphasis on patient-specific clinical factors
  • Reference to current MS treatment guidelines
  • Clear articulation of why alternatives are inappropriate

Counterforce Health specializes in turning insurance denials into evidence-backed appeals, helping patients navigate complex prior authorization requirements and appeal processes for specialty medications like Gilenya.

Patient Scripts & Templates

Script for Calling Cigna Customer Service

"Hi, I'm calling about prior authorization requirements for Gilenya, generic name fingolimod, for multiple sclerosis. My member ID is [ID number]. Can you tell me:

  • What tier is Gilenya on my formulary?
  • What are the specific PA requirements?
  • Are there step therapy requirements I need to meet?
  • What's the fastest way for my doctor to submit the request?"

Email Template for Medical Records Request

"Dear [Clinic Name],

I need complete medical records for my Cigna appeal for Gilenya (fingolimod) coverage. Please include:

  • All MS-related clinic notes from the past 2 years
  • MRI reports and imaging
  • Records of all previous MS medications tried
  • Lab results: CBC, liver function tests, EKG
  • Ophthalmology exam results

Please fax directly to Cigna at 1-866-873-8279 or provide copies for my appeal packet.

Thank you, [Your name and DOB]"

Costs & Savings Options

Manufacturer Support

  • Novartis Patient Assistance: Income-based free drug program
  • Gilenya Co-pay Program: Reduces out-of-pocket costs for eligible patients
  • Contact: 1-800-445-3692 or gilenya.com

Foundation Grants

  • National MS Society: Financial assistance for MS medications
  • Patient Access Network (PAN): MS-specific grant program
  • HealthWell Foundation: Copay assistance for qualifying patients

Florida-Specific Resources

  • Florida Association of Health Plans: Consumer assistance with coverage issues
  • 211 Florida: Connects patients with local pharmaceutical assistance programs

When to Escalate: Florida State Resources

File a Complaint with Florida DFS

When to use: If you suspect bad faith denial practices or procedural violations
Contact: 1-877-693-5236 or online at myfloridacfo.com/division/consumers
What to include:

  • All denial letters and correspondence
  • Documentation of proper appeal procedures followed
  • Evidence of coverage policy violations

Florida Office of Insurance Regulation

Role: Regulates insurance company practices in Florida
Use for: Systemic issues with Cigna's PA or appeals processes
Contact: Through the Department of Financial Services consumer complaint system

Note: Florida's external review process has resulted in coverage approvals for many specialty medications when proper medical evidence is presented. The state's independent medical reviewers are not affiliated with insurance companies and evaluate cases based solely on medical necessity and policy compliance.

FAQ

How long does Cigna PA take for Gilenya in Florida? Standard PA decisions typically take 2-5 business days. Expedited requests (for urgent medical situations) must be decided within 24-72 hours. If Cigna doesn't respond within the required timeframe, the request may be automatically approved.

What if Gilenya is non-formulary on my Cigna plan? You can request a formulary exception by demonstrating medical necessity and showing that preferred alternatives are inappropriate for your condition. This requires strong clinical documentation from your neurologist.

Can I request an expedited appeal in Florida? Yes, if your MS is rapidly progressing or if the delay in treatment poses a serious health risk. Expedited appeals must be decided within 72 hours for pre-service requests.

Does step therapy apply if I tried MS drugs with a different insurer? Medical records from previous insurers should count toward step therapy requirements. Ensure your neurologist includes documentation of all prior treatments, regardless of which insurance covered them.

What happens if my internal appeal is denied? Florida residents can request external review through the Department of Financial Services within 120 days of the final internal denial. This independent review is free and binding on Cigna if coverage is approved.

How much does Gilenya cost without insurance in Florida? Brand Gilenya can cost over $10,000 per month without insurance. Generic fingolimod is significantly less expensive. Patient assistance programs through Novartis can provide free medication for eligible patients.

Can my family doctor prescribe Gilenya, or does it need to be a specialist? Cigna typically requires prescription by a neurologist or MS specialist for PA approval. Family doctors generally cannot meet the specialist requirement for coverage.

What baseline tests are absolutely required before starting Gilenya? Required tests include: EKG (to rule out heart rhythm problems), comprehensive eye exam (macular edema screening), CBC with differential, and liver function tests. All should be completed within 6 months of the PA request.

Sources & Further Reading

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Coverage policies vary by plan and change frequently. Always verify current requirements with your insurance provider and consult your healthcare provider for medical decisions. For personalized assistance with complex prior authorization and appeal processes, consider consulting with specialists like Counterforce Health who can help translate insurance denials into targeted, evidence-backed appeals.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.